Trial Profile
Effect of natalizumab on surrogates of B cell function in blood and CSF.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 13 May 2016 New trial record